AVE vs NAN

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

AVE

AVECHO FPO [AVE]

53MEDIUM

NAN

NANOSONICS FPO [NAN]

52MEDIUM

Score Breakdown

AVE NAN
Technical
52
49
Catalyst
62
53
Sentiment
50
50
Fundamental
49
94
Momentum
75
41
Risk Gate
45
40

Key Metrics

AVE Metric NAN
$77.3MMarket Cap$965.5M
24.9MAvg Volume (20d)440K
N/AShort Interest+6.9%
$0.02752-Week High$4.770
$0.00452-Week Low$2.960
-2.4%Daily Change-0.3%
$0.020Reference Price$3.220
-182.9%ROE+10.1%
N/AProfit Margin+9.9%

Active Signals

AVE Signals

MACD momentum is losing steam
Beating the Small Ords index — relative strength of 1.65, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Very high P/S ratio (62.4x)
Revenue in sharp decline (-17%)
Small-cap ($20-100M)
Not enough chatter to gauge sentiment — defaulting to neutral

NAN Signals

MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (4.7x)
Moderate revenue growth (+9%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+3pts)

Ask Scout AI to compare AVE and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AVE vs NSB →AVE vs NTI →AVE vs NUZ →AVE vs NXN →AVE vs NYR →
AVE Full Analysis → NAN Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).